VB
Vectus Biosystems Limited
VBS.AX · ASX
$0.19 +0.00% (+$0.00)
1M +15.62%
Market Cap $9.35M
P/E Ratio -
Div. Yield -
ROE 1,775.31%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 9.65x
P/FCF N/A
P/FFO N/A
Growth
100 /100
Growing Rev. growth 198.00%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 231.15%
Op. margin 364.19%
Gross margin 99.84%
Quality
55 /100
Average Asset turnover 2.10x
ROA 794.70%
ROIC 838.52%
Debt
52 /100
Moderate Int. coverage -116.35x
Net debt/EBITDA -0.04x
Current ratio 0.58x
Stability
30 /100
Unstable Profitable years 0
EPS volatility 23.91%
Beta 0.29x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VBS.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tara Speranza
Employees
5
Headquarters
Rosebery